PharmiWeb.com - Global Pharma News & Resources

Healthcare - Press Releases

Date Title Company
30-May-2024 Anocca AB and Shinobi Therapeutics Announce Strategic Partnership to Develop Allogeneic TCR-T Cell Therapies in Oncology Anocca AB
30-May-2024 POA Pharma announces expansion into Austria, deepening its inborn metabolic disease footprint in Europe Galen Ltd
30-May-2024 New research suggests a BMI of 27 is obese, but that’s still not accurate enough, says expert London Medical Laboratory
29-May-2024 Lexicon Pharmaceuticals Selects Medidata to Help Advance First Non-Opioid Drug for Neuropathic Pain in Over Two Decades Lexicon Pharmaceuticals
29-May-2024 ScaleReady announces $20 Million G-Rex® grant program for the advancement of cell and gene therapy (CGT) development and manufacturing CellReady LLC
29-May-2024 NowPatient Expands Services with Pharmacogenetics Testing Deals in the US and Germany NowPatient
29-May-2024 Resolution Therapeutics Announces Upcoming Scientific Presentations at EASL Congress 2024 Resolution Therapeutics
29-May-2024 Adcendo ApS Announces Extension of Series A Financing to EUR 98M to Further Bolster its First-in-Class ADC Pipeline Adcendo
29-May-2024 Kromek Group plc - FY 2024 Trading Update Kromek Group plc
29-May-2024 Anaveon announces IND approval of ANV600-001 (EXPAND) Phase I/II clinical study Anaveon
29-May-2024 Integrated Biosciences Collaborate with Illumina Ventures Labs to Design Novel Therapeutics Targeting the Transcriptome Integrated Biosciences
29-May-2024 Cancer Stem Cells Market Future Prospects, Trends, Growth, Key Player SWOT Analysis by 2031| DataM Intelligence
28-May-2024 Omnia Technologies acquires ACMI, SACMI Beverage and SACMI Labelling to create a leading provider of turnkey high-speed beverage automation solutions Omnia Technologies
28-May-2024 STORM Therapeutics to Present Interim Phase 1 Clinical Data on its METTL3 RNA Methyltransferase Inhibitor STC-15 at ASCO 2024 STORM Therapeutics Ltd
28-May-2024 First patients in Spain to be treated with Pepaxti Oncopeptides AB
28-May-2024 Medigene AG Expands its End-to-End Platform by Submitting Three Patents to the European Patent Office Medigene AG
28-May-2024 Poor access to essential surgery is costing lives - study University of Birmingham
28-May-2024 Celltrion receives European Commission approval of Omlyclo® (CT-P39), the first and only omalizumab biosimilar approved in Europe Celltrion
28-May-2024 Half of Europe's population gets sunburned at least once a year and the majority never get their skin checked by a professional Almirall
23-May-2024 Global oncology trial investigator sites increase by half in five years, finds new Phesi analysis Phesi